Maxcyte, INC Schedule 13D activist filings

River Global Investors LLP reports a shift in beneficial ownership of Maxcyte, Inc. equity due to an acquisition of its parent entity, with a portion of voting rights transferring to Liontrust Investment Partners.

River Global Investors LLP has reported a beneficial ownership of 6,529,027 shares, representing 6.1% of the outstanding equity in Maxcyte, Inc., acquired through open-market transactions.

River Global Investors LLP has disclosed a 5.1568% beneficial ownership stake in MAXCYTE, INC., acquiring over 5.4 million equity shares.